Skip secondary menu

LBD Participant List


Biomarkers for Lewy Body Disease, Pathway to Discovery and Validation

April 25-27, 2010
Omni Shoreham Hotel
Washington, D.C.
Workshop    Agenda    Executive Summary

 

PARTICIPANT LIST

Dag Aarsland, M.D., Ph.D.
Professor
Stavanger University Hospital

Charles Adler, M.D., Ph.D.
Professor of Neurology
Mayo Clinic Arizona

Liana Apostolova, M.D.
Assistant Professor
Department of Neurology
University of California, Los Angeles

Thomas Beach, M.D., Ph.D.
Director, Civin Laboratory for Neuropathology
Sun Health Research Institute

James Beck, Ph.D.
Director of Research Programs
Parkinson’s Disease Foundation

Debra Bergstrom, Ph.D.
Program Analyst
Division of Extramural Research
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Bradley Boeve, M.D.
Professor
Department of Neurology
Mayo Clinic

Nicolaas Bohnen, M.D., Ph.D.
Associate Professor
University of Michigan
Domino’s Farms, Lobby B-1000

David Brooks, M.D., D.Sc.
Professor
Imperial College London
Hammersmith Hospital

Alice Chen-Plotkin, M.D.
Assistant Professor of Neurology
University of Pennsylvania School of Medicine

Roderick Corriveau, Ph.D.
Program Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Dennis Dickson, M.D.
Professor
Mayo Clinic Jacksonville

John Duda, M.D.
Director
Parkinson’s Disease Research, Education and Clinical Center
Philadelphia VA Medical Center

Peggy Eastman
Writer
Neurology Today

Omar El-Agnaf, Ph.D.
Professor
Department of Biochemistry
Faculty of Medicine and Health Sciences
United Arab Emirates University

Tanis Ferman, Ph.D.
Associate Professor
Department of Psychiatry and Psychology
Mayo Clinic College of Medicine

Howard Fillit, M.D.
Executive Director
Alzheimer’s Drug Discovery Foundation

Douglas Galasko, M.D.
Professor
University of California, San Diego

Wendy Galpern, M.D., Ph.D.
Program Director, Clinical Trials
National Institute of Neurological Disorders and Stroke
National Institutes of Health

James Galvin, M.D., M.P.H.
Professor
New York University

Stephen Gomperts, M.D., Ph.D.
Instructor
Massachusetts General Hospital

Rachel Gross, M.D.
Fellow
University of Pennsylvania School of Medicine
Pennsylvania Hospital

John Growdon, M.D.
Neurologist
Massachusetts General Hospital

Angela Herron
President, Board of Directors
Lewy Body Dementia Association

Lawrence Honig, M.D., Ph.D.
Professor of Clinical Neurology
Columbia University Medical Center
Sergievsky Center/Taub Institute

Howard Hurtig, M.D.
LBDA SAC Meeting Planning Committee
University of Pennsylvania

Clifford Jack, Jr., M.D.
Professor of Radiology
Mayo Clinic

Keith Johnson, M.D.
Associate Professor
Massachusetts General Hospital

Un Kang, M.D.
Professor
University of Chicago

Daniel Kaufer, M.D.
Director, UNC Memory Disorders Program
University of North Carolina

Holli Kawadler, Ph.D.
Research Officer
Michael J. Fox Foundation

David Lee, M.P.A.
Deputy Director, Biomarkers Consortium
Foundation for NIH

Virginia Lee, Ph.D.
Director, Center for Neurodegenerative Disease Research
University of Pennsylvania School of Medicine

James Leverenz, M.D.
Associate Professor
Department of Neurology
University of Washington
VA Puget Sound Health Care System

Ti Lin, Ph.D.
Program Analyst
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Carol Lippa, M.D.
Professor of Neurology; Director, Memory Disorders
Drexel University College of Medicine

Oscar Lopez, M.D.
Professor of Neurology
University of Pittsburgh

Kenneth Marek, M.D.
President
Institute for Neurodegenerative Disorders

Debra McCoy-Massey, M.A.
Vice President
Lewy Body Dementia Association

Ian McKeith, M.D.
Professor of Old Age Psychiatry
Newcastle University
Institute for Aging and Health

Satoshi Minoshima, M.D., Ph.D.
Professor and Vice Chair
Department of Radiology
University of Washington

Thomas Montine, M.D., Ph.D.
Professor
Department of Pathology
University of Washington

James Morley, M.D., Ph.D.
Fellow
University of Pennsylvania
Parkinson’s Disease and Movement Disorders Center

Christopher Morris, Ph.D.
Senior Lecturer
Wolfson Unit of Clinical Pharmacology
Newcastle University
Medical Toxicology Centre

Mendie Nord
Director of Development
Lewy Body Dementia Association

John O’Brien, D.M., FRCPsych
Professor of Old Age Psychiatry
Newcastle University

Marco Onofrj, M.D.
Professor of Neurology
University of Chieti, Italy

Creighton Phelps, Ph.D.
Director
National Institute on Aging
National Institutes of Health

Andreas Puschmann, M.D.
Mayo Clinic Jacksonville

Bernard Ravina, M.D., MSCE
Associate Professor
University of Rochester

Lorenzo Refolo, Ph.D.
Program Officer
National Institute on Aging
National Institutes of Health

John Reynders, Ph.D., M.B.A.
Vice President, Head of Integrative Neurosciences and Biomarkers
Johnson & Johnson, Pharmaceutical Research & Development, LLC

Gary Romano, M.D., Ph.D.
Head, Neuroscience Biomarkers
Janssen Pharmaceuticals

Alexander Runko, Ph.D.
Program Analyst
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Michael Schlossmacher, M.D., Ph.D.
Ottawa Hospital Research Institute
University of Ottawa

Walter Schulz-Schaeffer
Assistant Professor
Department of Neuropathology
Prion and Dementia Research Unit
University Medical Center, Germany

Les Shaw, Ph.D.
Director, Biomarker Research Laboratory
University of Pennsylvania Medical Center

Diana Shineman, Ph.D.
Assistant Director for Scientific Affairs
Alzheimer’s Drug Discovery Foundation

Beth-Anne Sieber, Ph.D.
Program Officer
Neurodegeneration Cluster
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Andrew Singleton, Ph.D.
Investigator
National Institute on Aging
National Institutes of Health

Judy Siuciak, Ph.D.
Scientific Program Manager
Foundation for NIH, Biomarkers Consortium

Daniel Skovronsky, M.D., Ph.D.
President and Chief Executive Officer
Avid Radiopharmaceuticals, Inc.

Gabrielle Strobel
Managing Editor
Alzheimer Research Forum

Margaret Sutherland, Ph.D.
Program Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Angela Taylor
Program Director
Lewy Body Dementia Association

John Trojanowski, M.D., Ph.D.
Director, Institute on Aging
Co-Director, Center for Neurodegenerative Disease Research
University of Pennsylvania School of Medicine

Debby Tsuang, M.D., M.Sc.
Professor
University of Washington
VA Puget Sound Health Care System

Marc Walton, M.D., Ph.D.
Associate Director
Office of Translational Sciences
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Daniel Weintraub, M.D.
Associate Professor
University of Pennsylvania

Helen Whitworth, M.S., B.S.N.
Co-Founder
Lewy Body Dementia Association

James Whitworth
Co-Founder
Lewy Body Dementia Association

Zbigniew Wszolek, M.D.
Professor and Consultant of Neurology
Mayo Clinic Jacksonville

Last updated December 23, 2013